← All stocks

Sensus Healthcare, Inc.

SRTS Net selling
CIK 0001494891 #4698 in the set updated 17 Sep 2026
Bought (120 mo)
$976.39K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.55M
$0.00 on a plan · $257.41K straight out of an exercise
Sold at will
$8.29M
166 of 169 sales
Net
−$7.57M
−$7.31M against sales at will

By person

15 insiders · 197 transactions
7.1×

Joseph C. Sardano holds 7.1 times base salary in stock. $4.32M of shares against $600.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph C. Sardano last reported holding, valued at $3.54, the price Common Stock was last bought or sold at on the open market here, on 31 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Sardano Joseph C
CHIEF EXECUTIVE OFFICER
$303.37K (6)
$5.33M (42)
−$5.03M
1,220,293
7.41%
$4.32M
−25.5%
Cohen Stephen Brad
EXECUTIVE VICE PRESIDENT
$1.11M (35)
−$1.11M
830,585
5.05%
$2.94M
−15.9%
O'Rear Samuel
Director
$59.85K (2)
$710.20K (2)
−$650.34K
143,570
0.8721%
$507.95K
0.0%
Sachetta Eric
Director
$554.43K (11)
+$554.43K
296,877
1.80%
$1.05M
+123.7%
Golin Richard
EXECUTIVE VICE PRESIDENT
$476.17K (31)
−$476.17K
924,236
5.61%
$3.27M
−7.0%
Fishman Kalman
CHIEF TECHNOLOGY OFFICER
$425.03K (29)
−$425.03K
931,007
5.66%
$3.29M
−6.4%
Soro Nicolas
CHIEF OPERATING OFFICER
$102.00K (1) scheduled
−$102.00K
3,546
0.0215%
$12.55K
−29.5%
Heinrich John
Director
$28.60K (1)
$123.42K (2)
−$94.82K
59,940
0.3641%
$212.07K
+50.1%
Rampolla Javier
CHIEF FINANCIAL OFFICER
$2.98K (1)
$84.78K (1) scheduled
−$81.80K
40,745
0.2475%
$144.16K
+128.8%
McCall William H
Director
$75.40K (2)
−$75.40K
574,387
3.49%
$2.03M
−33.2%
Sardano Michael
PRESIDENT AND GENERAL COUNSEL
$27.14K (7)
$70.63K (1) scheduled
−$43.48K
158,839
0.9649%
$561.97K
+764.8%
Levine Arthur
CHIEF FINANCIAL OFFICER
$31.14K (23)
−$31.14K
186,709
1.13%
$660.58K
−28.7%
Petrelli Anthony Benedict
Director
66,466
0.4038%
$235.16K
+303.7%
Cornish Megan
Director
32,000
0.1944%
$113.22K
+1,500%
Martinez Magdalena
CHIEF OPERATING OFFICER
9,759
0.0593%
$34.53K
−7.1%
Insider
Date
Role
Action
Shares
Price
Amount
Sachetta Eric
31 Aug 2026
Director
Buy
27,304
$3.54
$96.60K
Sachetta Eric
28 Aug 2026
Director
Buy
37,537
$3.44
$129.01K
Sachetta Eric
27 Aug 2026
Director
Buy
10,925
$3.18
$34.75K
Sachetta Eric
26 Aug 2026
Director
Buy
9,708
$3.29
$31.93K
Sachetta Eric
24 Aug 2026
Director
Buy
34,697
$3.25
$112.90K
Sachetta Eric
21 Aug 2026
Director
Buy
7,000
$3.25
$22.78K
Sachetta Eric
20 Aug 2026
Director
Buy
24,000
$3.13
$75.07K
Sardano Joseph C
20 Aug 2026
CHIEF EXECUTIVE OFFICER
Buy
20,000
$3.02
$60.49K
Sachetta Eric
12 May 2026
Director
Buy
1,500
$3.34
$5.00K
Sachetta Eric
24 Feb 2026
Director
Buy
2,000
$3.81
$7.62K
Sachetta Eric
21 Nov 2025
Director
Buy
7,000
$3.93
$27.51K
Sardano Michael
18 Nov 2025
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$3.80
$3.80K
Sardano Joseph C
18 Nov 2025
CHIEF EXECUTIVE OFFICER
Buy
25,000
$4.03
$100.75K
Sachetta Eric
13 Nov 2025
Director
Buy
2,500
$4.50
$11.25K
Sardano Michael
11 Nov 2025
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$4.26
$4.26K
Sardano Michael
13 Aug 2025
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$3.37
$3.37K
Sardano Michael
10 Feb 2025
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$5.95
$5.95K
Rampolla Javier
10 Feb 2025
CHIEF FINANCIAL OFFICER
Buy
501
$5.95
$2.98K
Sardano Joseph C
14 Sep 2023
CHIEF EXECUTIVE OFFICER
Buy
10,000
$2.88
$28.77K
Sardano Michael
28 Aug 2023
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$2.99
$2.99K
Sardano Joseph C
8 Aug 2023
CHIEF EXECUTIVE OFFICER
Buy
10,000
$3.86
$38.57K
Sardano Michael
8 Aug 2023
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$3.78
$3.78K
Heinrich John
11 May 2023
Director
Buy
10,000
$2.86
$28.60K
Sardano Joseph C
10 May 2023
CHIEF EXECUTIVE OFFICER
Buy
7,925
$3.00
$23.74K
O'Rear Samuel
9 May 2023
Director
Buy
17,564
$3.00
$52.67K
Sardano Joseph C
9 May 2023
CHIEF EXECUTIVE OFFICER
Buy
17,075
$2.99
$51.06K
Sardano Michael
8 May 2023
PRESIDENT AND GENERAL COUNSEL
Buy
1,000
$3.00
$3.00K
O'Rear Samuel
8 May 2023
Director
Buy
2,436
$2.95
$7.18K

What was left out

Form 4 filings counted 154
Amendments (4/A) skipped 12
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 166
Transactions with no price 0
Shares from compensation/vesting 856,759
Sales filed before the plan box existed 164
History held since 1 Dec 2016